NCT05106101View on ClinicalTrials.gov

L-glutamine Treatment in Patients With Diverticulosis

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Diverticulosis, Colonic
Interventions
DRUG

L-glutamine

L-glutamine oral powder in 5 gram packet

Trial Locations (3)

78229

Clinical Trials of Texas, Inc., San Antonio

90502

The Lundquist Institute at Harbor-UCLA Medical Center, Torrance

93003

Ventura Clinical Trials, Ventura

All Listed Sponsors
lead

Emmaus Medical, Inc.

INDUSTRY

NCT05106101 - L-glutamine Treatment in Patients With Diverticulosis | Biotech Hunter | Biotech Hunter